DF

David B. Frennesson

BS Bristol-Myers Squibb: 20 patents #232 of 3,969Top 6%
VL Viiv Healthcare Uk (No.5) Limited: 1 patents #52 of 94Top 60%
📍 Naugatuck, CT: #5 of 206 inventorsTop 3%
🗺 Connecticut: #1,850 of 34,797 inventorsTop 6%
Overall (All Time): #204,842 of 4,157,543Top 5%
21
Patents All Time

Issued Patents All Time

Showing 1–21 of 21 patents

Patent #TitleCo-InventorsDate
12110290 Triazolopyridinyl compounds as kinase inhibitors Guanglin Luo, Jie Chen, Carolyn Diane Dzierba, Junqing Guo, Amy C. Hart +9 more 2024-10-08
11767322 Triazolopyridinyl compounds as kinase inhibitors Guanglin Luo, Jie Chen, Carolyn Diane Dzierba, Junqing Guo, Amy C. Hart +9 more 2023-09-26
11505543 4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replication Makonen Belema, John A. Bender, Eric P. Gillis, Christiana I. Iwuagwu, John F. Kadow +8 more 2022-11-22
10745382 Compounds useful as immunomodulators Kap-Sun Yeung, Timothy P. Connolly, Katharine A. Grant-Young, Piyasena Hewawasam, David R. Langley +9 more 2020-08-18
10617675 Hepatitis C virus inhibitors Piyasena Hewawasam, Omar D. Lopez, Van N. Nguyen, Mark G. Saulnier, Yong Tu +8 more 2020-04-14
10590105 1,3-dihydroxy-phenyl derivatives useful as immunomodulators Kap-Sun Yeung, Katharine A. Grant-Young, Juliang Zhu, Mark G. Saulnier, Zhaoxing Meng +1 more 2020-03-17
10144706 Compounds useful as immunomodulators Kap-Sun Yeung, Katharine A. Grant-Young, Juliang Zhu, Mark G. Saulnier, David R. Langley +7 more 2018-12-04
9775831 Combinations comprising biphenyl derivatives for use in the treatment of HCV Mark G. Saulnier, Makonen Belema 2017-10-03
9266880 Substituted azaindazole compounds Joel Francis Austin, Mark G. Saulnier 2016-02-23
9169295 Macrocycles and macrocycle stabilized peptides Mark G. Saulnier, Dolatrai M. Vyas, David R. Langley 2015-10-27
8673922 Azaindazole compounds Upender Velaparthi, Mark G. Saulnier, Joel Francis Austin, Audris Huang, James Aaron Balog +1 more 2014-03-18
8592579 Pyrrolotriazine kinase inhibitors Mark D. Wittman, Harold Mastalerz, Kurt Zimmermann, Mark G. Saulnier, Upender Velaparthi +6 more 2013-11-26
8445676 Pyrrolotriazine kinase inhibitors Ashok Vinayak Purandare, Muthoni G. Kamau, Lalgudi S. Harikrishnan, Mark G. Saulnier 2013-05-21
7879855 Pyrrolotriazine kinase inhibitors Mark D. Wittman, Harold Mastalerz, Kurt Zimmermann, Mark G. Saulnier, Upender Velaparthi +6 more 2011-02-01
7534792 Pyrrolotriazine kinase inhibitors Mark D. Wittman, Harold Mastalerz, Kurt Zimmermann, Mark G. Saulnier, Upender Velaparthi +6 more 2009-05-19
7223757 Tyrosine kinase inhibitors Mark D. Wittman, Neelakantan Balasubramanian, Upender Velaparthi, Kurt Zimmermann, Mark G. Saulnier +6 more 2007-05-29
7081454 Tyrosine kinase inhibitors Mark D. Wittman, Neelakantan Balasubramanian, Upender Velaparthi, Kurt Zimmermann, Mark G. Saulnier +6 more 2006-07-25
6855698 Topoisomerase I selective cytotoxic sugar derivatives of indolopyrrolocarbazoles Edward H. Ruediger, Mark G. Saulnier, Francis Beaulieu, Carol Bachand, Neelakantan Balusubramanian +5 more 2005-02-15
6686385 Anhydro sugar derivatives of indolocarbazoles Mark G. Saulnier, Edward H. Ruediger, Neelakantan Balasubramanian, Mikael Mahler, Kurt Zimmermann 2004-02-03
6677450 Topoisomerase inhibitors Mark G. Saulnier, Edward H. Ruediger, Neelakantan Balasubramanian, Mikael Mahler, Francis Beaulieu +1 more 2004-01-13
6610727 Anhydro sugar derivatives of indolocarbazoles Mark G. Saulnier, Edward H. Ruediger, Neelakantan Balasubramanian, Mikael Mahler, Kurt Zimmermann 2003-08-26